New Science Ventures
Venture capitalGreenwich · Seed–Late Stage · 7 people tracked
Also known as NSV · NSV MANAGEMENT LLC
Investment thesis
NSV pursues a science-first investment strategy focused on companies with fundamental, science-based innovations protected by strong intellectual property. The firm adopts company-specific evaluations often contrarian in nature, deploys capital where scientific breakthroughs occur regardless of geographic hubs, builds development-stage-appropriate teams using virtual business models where applicable, and partners flexibly in syndicates. NSV maintains patient capital to support companies through significant value inflection points.
Source: firm website, verified Jul 21, 2026.
Team · 7 people
from the firm's website
What they invest in
from 2 of 30 portfolio companiesAI & Machine Learning ×2Deep Tech ×1Hardware ×1Mobility & Transportation ×1Robotics ×1Semiconductors ×1
HQs:United States×3
Investments · 30 tracked
founders shown can be your intro pathGlydways builds an on-demand public transit system using autonomous vehicles that operates on existing infrastructure, moving more passengers than rail while costing 90% less to build and operate. The system serves cities and municipalities seeking cost-effective, sustainable mass transportation solutions.
AI & Machine LearningMobility & TransportationRoboticsBrisbane, US
Mark Seeger(Co-CEO, Founder)inBlake Barber(Co-CEO, CTO)inZach Zeliff(Co-Founder, Chief Product Solutions)in
Sagence AI develops semiconductor technology based on analog in-memory compute methods to enable efficient AI computing for edge and data center applications. The company targets developers and customers building practical AI systems across various industries.
AI & Machine LearningDeep TechHardwareSemiconductors
Vishal Sarin(Founder, President & CEO)
San Diego, US
Sheila S. Gujrathi(Director)Mark S. Forman(Executive Officer)William S. White(Director)Allison S. Hulme(Director)
Frequently asked questions
- What stage does New Science Ventures invest at?
- New Science Ventures invests at the Seed, Series A, Series B, Late Stage stages.
- What is New Science Ventures's typical check size?
- New Science Ventures typically writes checks of $2M – $8M.
- What sectors does New Science Ventures focus on?
- New Science Ventures focuses on AI & Machine Learning, Biotech, Deep Tech, Digital Health, Healthtech, Medical Devices.
- Where is New Science Ventures located?
- New Science Ventures is headquartered in Greenwich, US.
- Does New Science Ventures lead rounds?
- Yes, New Science Ventures leads investment rounds.
Similar investors
DCVC is a deep tech venture capital firm with over a dozen years of experience backing entrepreneurs using computational approaches to solve trillion-dollar problems across industries including AI, climate, materials science, robotics, space, and biology.
GV is Alphabet's venture capital arm, established in 2009 as Google Ventures. Operating with long time horizons and over $13 billion in assets under management, the firm invests across technology and life sciences sectors from seed to growth stages, supporting 400 active portfolio companies across North America, Europe, and Israel.
Khosla Ventures is a technology-focused investment firm that seeks companies leveraging disruptive technological advances to solve large-scale problems across multiple industries. The firm emphasizes proprietary technology, business model innovation, and early-stage, bold investments with unfair advantages.
Venrock is a venture capital firm investing across healthcare, technology, and deeptech sectors, with a portfolio spanning from early-stage therapeutics to established technology companies.
A venture capital firm that supports founders developing transformative solutions across interconnected systems, with a particular focus on leveraging artificial intelligence and related technologies to advance health and human flourishing.